Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer, Non-small Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02688166
What this trial is testing

Cardiac MRI Biomarker Testing (GCC 1618)

Who this might be right for
Breast CancerLung Cancer (Non-Small Cell)Thoracic Cancer+2 more
University of Maryland, Baltimore 6
Testing effectiveness (Phase 2)Looking for participantsNCT07259226
What this trial is testing

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

Who this might be right for
Advanced Breast CancerAdvanced Gastric CancerAdvanced Urothelial Cancer+1 more
UNICANCER 400
Testing effectiveness (Phase 2)Study completedNCT00059943
What this trial is testing

Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

Who this might be right for
Breast CancerLung CancerProstate Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Testing effectiveness (Phase 2)Ended earlyNCT02554812
What this trial is testing

Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Who this might be right for
Advanced Cancer
Pfizer 409
Early research (Phase 1)Looking for participantsNCT06545331
What this trial is testing

Study of XB010 in Subjects With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsEsophageal Squamous Cell CancerHead and Neck Squamous Cell Cancer+3 more
Exelixis 396
Not applicableUnknownNCT00336609
What this trial is testing

TRIAD Burden of Illness Mucositis Study

Who this might be right for
Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)
TRIAD Burden of Illness 1,600
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Ended earlyNCT03549000
What this trial is testing

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
Novartis Pharmaceuticals 127
Early research (Phase 1)Ended earlyNCT01930292
What this trial is testing

Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies

Who this might be right for
Solid Tumors
Debiopharm International SA 31
Early research (Phase 1)UnknownNCT05780307
What this trial is testing

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer+3 more
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 48
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06603987
What this trial is testing

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Who this might be right for
Thoracic Solid Malignant Tumor
Stella Pharma Corporation 30
Early research (Phase 1)Study completedNCT01300533
What this trial is testing

BIND-014 Given to Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerCancerSolid Tumors
BIND Therapeutics 58
Not applicableActive Not RecruitingNCT01505400
What this trial is testing

Integrated Molecular Profiling in Advanced Cancers Trial

Who this might be right for
Breast CancerNon-small Cell Lung CancerColorectal Cancer+7 more
University Health Network, Toronto 3,026
Early research (Phase 1)Ended earlyNCT04665921
What this trial is testing

SGN-STNV in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungHER2 Negative Breast NeoplasmsOvarian Neoplasms+9 more
Seagen Inc. 111
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Testing effectiveness (Phase 2)WithdrawnNCT00824811
What this trial is testing

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

Who this might be right for
Epiphora
M.D. Anderson Cancer Center
Early research (Phase 1)Temporarily pausedNCT05967533
What this trial is testing

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+13 more
University of California, Davis 100
Early research (Phase 1)Ended earlyNCT02576665
What this trial is testing

Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Who this might be right for
Colorectal CancerTriple Negative Breast CancerPancreatic Cancer+9 more
Tocagen Inc. 21
Next Page